Clinical characteristics and management of patients with nonalcoholic steatohepatitis in a real-world setting: analysis of the Ipsos NASH therapy monitor database
Abstract Background Nonalcoholic steatohepatitis (NASH) is the more severe, inflammatory type of nonalcoholic fatty liver disease (NAFLD). NASH, a leading indication for liver transplantation, is growing in prevalence. The extent of liver fibrosis, ranging from fibrosis stage (FS) of none (F0) to ci...
Main Authors: | Karishma Shelley, Amy Articolo, Rakesh Luthra, Michael Charlton |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2023-05-01
|
Series: | BMC Gastroenterology |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12876-023-02794-4 |
Similar Items
-
The burden of nonalcoholic steatohepatitis (NASH) in the United States
by: Elliot B. Tapper, et al.
Published: (2023-04-01) -
Clinical and histological features of nonalcoholic steatohepatitis in Iranian patients
by: Haghpanah Babak, et al.
Published: (2003-10-01) -
Nonalcoholic Fatty Liver Disease and MicroRNAs: A Weighty Consideration
by: Sanjukta Mishra, et al.
Published: (2023-01-01) -
Nonalcoholic steatohepatitis and hepatocellular carcinoma: Brazilian survey
by: Helma P. Cotrim, et al.
Published: (2016-05-01) -
Nonalcoholic Steatohepatitis (NASH) and Atherosclerosis: Explaining Their Pathophysiology, Association and the Role of Incretin-Based Drugs
by: Eleftheria Galatou, et al.
Published: (2022-05-01)